Fotemustine plus dacarbazine in advanced stage III malignant melanoma
- 31 December 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (11) , 1814-1816
- https://doi.org/10.1016/0959-8049(92)90010-y
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasesCancer, 1990
- Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanomaCancer Chemotherapy and Pharmacology, 1990
- Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma IV. Late results after complete response to chemotherapy (central oncology group protocols 7130, 7131, and 7131A)Cancer, 1984
- Results with methyl-CCNU and DTIC in metastatic melanomaCancer, 1977
- Chemotherapy of malignant melanomaCancer, 1972
- Combination Phase 1 -II Study of Imidazole Carboxamide (NCS 45388)Oncology, 1972
- Characteristics of prognosis and response to an imidazole carboxamide in malignant melanomaClinical Pharmacology & Therapeutics, 1971